Clinical Trial Update: Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of difluprednate 0.05% for the treatment of anterior uveitis has completed with results posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis

Drugs mentioned

• Durezol (difluprednate)

Snippet

Sponsor: Alcon Research | Conditions: Endogenous Anterior Uveitis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-15